cro.directory
← Back to posts

CRO Daily News — September 29, 2026

By BioBM ·

At a glance

Related topics: Clinical technology, Clinical development

Quotient Sciences Deploys AI Formulation Platform for Acesion Pharma Atrial Fibrillation Pipeline

Operational Impact

Quotient Sciences' AI formulation platform demonstrates a competitive differentiation in translational pharmaceutics that may influence CRO vendor selection for biotech sponsors seeking faster formulation decision-making and earlier clinical readiness.

Source: PharmaSource RSS

References

  1. PharmaSource RSS — Quotient Sciences Deploys AI Formulation Platform for Acesion Pharma Atrial Fibrillation Pipeline

Deep dive by email

Get the next CRO deep dive by email. One message when it publishes. No daily digest.

Markdown mirror: /posts/daily-news-2026-09-29-cro.md